‌

US Patent 11707532 Compositions and methods of treating muscle dystrophy

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Current Assignee
Avidity Biosciences
Avidity Biosciences
1
Date Filed
August 8, 2022
1
Date of Patent
July 25, 2023
1
Patent Applicant
Avidity Biosciences
Avidity Biosciences
1
Patent Application Number
17818319
1
Patent Citations
‌
US Patent 7528126 Pyrrolobenzodiazepines
1
‌
US Patent 7612062 Pyrrolobenzodiazepines
1
‌
US Patent 7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
1
‌
US Patent 7691997 Functional and hyperfunctional siRNA
1
‌
US Patent 7704924 Library of compounds comprising pyrrolobenzodiazepine moieties
1
‌
US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs
1
‌
US Patent 7750116 Antibody drug conjugate metabolites
1
‌
US Patent 7833992 Conjugates and compositions for cellular delivery
1
‌
US Patent 7850975 Chemically programmable immunity
1
‌
US Patent 7893245 Interfering RNA molecules
1
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
11707532
1
Patent Primary Examiner
‌
Phuong Huynh
1
Industry
Request Data

Find more entities like US Patent 11707532 Compositions and methods of treating muscle dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.